Skip to main content
NeuronFeed
CATEGORY

Best Medical AI Tools

48 tools compared · 2026

Ambient scribes, clinical search, and FDA-cleared imaging tools deployed at the point of care

48 ai medical startups tracked, with the largest concentration in US. Total tracked funding: $5.3B.

Tracked
48
Total Raised
$5.3B
Countries
10
Active Deals
0

Top by score

View all 48 →

Funding by year — AI Medical

2020 → 2026
$75M
’20
$322M
’21
$20M
’22
$65M
’23
$168M
’24
$1.6B
’25
$589M
’26

Market overview

OpenEvidence closed a $735M Series D in January 2026 to push its physician-facing clinical search across more than 40% of US doctors, the largest deployment in the category. Ambience Healthcare reached $243M Series C as the leading ambient-scribe product against Suki AI's $70M and a still-private Heidi AI. Tempus and Recursion straddle this category and ai-drug-discovery, while Lunit and Harrison.ai dominate AI radiology in oncology and chest imaging respectively. Glass Health and K Health build clinical-decision-support layers on top of the EHR, and Color Health rebuilt cancer-care navigation around an AI copilot. FDA 510(k) clearances for AI-as-medical-device are now flowing at a record pace.

Key trends 2026

  • Ambient scribes reach saturation pricing. Suki, Ambience, and Heidi compete at $200-400/clinician/mo, down from $600+ a year ago.
  • OpenEvidence becomes the doctor-facing search default. $735M Series D funds outpaces any UpToDate-replacement attempt before it.
  • FDA AI/ML 510(k) clearances accelerate. 2024-2026 device list growth tracks above 200/year, vs ~30/year pre-2020.

Benchmarks vs global

Largest 2026 round
$735M (OpenEvidence Series D)
vs $243M Ambience Series C
Ambient scribe seat price
$200-400/mo
vs $600+/mo in 2024
FDA AI/ML device clearances
200+/yr (2024-26)
vs ~30/yr pre-2020

Top countries

By startup count

Stage breakdown

Latest round type
  • Series A 16
  • Series B 8
  • Series D 5
  • Series C 5
  • Seed 4
  • Series E 2
  • Venture Round 1
  • IPO 1

Top investors backing AI Medical

See all →

FAQ

Frequently asked

How is ai-medical different from ai-drug-discovery?
AI-medical covers point-of-care clinical tools — scribes, decision support, imaging, search (OpenEvidence, Ambience, Suki, Lunit). AI-drug-discovery covers preclinical R&D — molecular generation, target ID, protein folding (Recursion, Insilico, Chai). A few firms (Tempus, Recursion) operate in both.
Which AI medical startup has raised the most?
OpenEvidence leads at $735M total funding after its January 2026 Series D, focused on a clinical search product used by US physicians. Ambience Healthcare follows at $243M Series C for ambient documentation, then Suki AI at $70M.
Are these tools FDA-cleared?
It depends on intended use. Diagnostic imaging products (Lunit, Harrison.ai modules, NIRAMAI) carry FDA 510(k) or CE Mark clearance. Documentation and search tools (Ambience, Suki, OpenEvidence) typically operate as non-device clinical software, which has lighter regulatory requirements.

Recent rounds in AI Medical

All rounds →
Date Startup Round Amount
May 2026 NVision Series B $55M
Apr 2026 Aidoc Series E $150M
Mar 2026 XCath Series C $30M
Mar 2026 Procode AI Seed $4M
Jan 2026 OpenEvidence Series D $250M
Jan 2026 Surgerii Robotics Series D $100M
Dec 2025 Valerie Health Series A $30M
Dec 2025 a2z Radiology AI Seed $4.5M

All AI Medical startups

Page 1

Treeline Biosciences

US est. 2021

Computational and experimental drug discovery for hard-to-drug cancer targets

Raised
$1.1B
Stage
S-A
82

Aidoc

PRIVATE
Israel est. 2016

Clinical AI foundation model for medical imaging and triage

Raised
$500M
Stage
S-E
77

Qure.ai

est. 2016
Raised
$123M
Stage
S-C
76

Eko Health

est. 2013
Raised
$41M
Stage
S-D
73

Color Health

US

Reinventing cancer care with direct clinical access, speed, and expert support for better outcomes and lower costs.

Raised
$482M
Stage
S-E
72

Suki

Raised
$73M
Stage
S-D
72

Quibim

ES est. 2012

AI-powered imaging biomarkers for precision medicine

Raised
$50M
Stage
S-A
71

Neko Health

SE est. 2018

AI-powered full-body health scans for preventive medicine.

Raised
$325M
Stage
S-B
71

VideaHealth

US est. 2018

FDA-cleared dental AI that detects disease on X-rays in real time

Raised
$60M
Stage
S-B
71

voize

DE est. 2020

AI voice companion that handles documentation for nurses

Raised
$50M
Stage
S-A
70

NVision

DE est. 2016

Quantum-enhanced MRI that images disease metabolism in real time

Raised
$120M
Stage
S-B
70

Navina

Raised
$55M
Stage
S-C
70

Suki AI

Verified
US est. 2017

AI voice assistant for clinicians

Raised
$165M
Stage
S-D
68

Triomics

US est. 2021

Oncology-specific AI agents that turn unstructured EHRs into structured cancer data

Raised
$36M
Stage
S-B
68

Tandem Health

SE est. 2023

AI-native operating system for clinical workflows, starting with an ambient scribe

Raised
$59.5M
Stage
S-A
67

Prenosis

est. 2014
Raised
$60M
Stage
S-A
67

Cerebriu

DK est. 2018

Real-time AI triage and protocol optimization for brain MRI

Raised
$19M
Stage
S-A
66

Upheal

US est. 2021

AI-native EHR and clinical notes for mental health therapists

Raised
$14.3M
Stage
S-A
66

Humata Health

US est. 2023

Touchless, AI-driven prior authorization connecting providers and payers

Raised
$25M
Stage
VENTURE ROUND
66

Capstan Medical

US est. 2018

Robotic and catheter-delivered implants for minimally invasive heart valve repair

Raised
$184M
Stage
S-C
66

Regard

Raised
$61M
Stage
S-B
66

Kintsugi

US est. 2019

Voice biomarker AI to detect depression and anxiety from speech

Raised
$28M
Stage
S-A
65

Surgerii Robotics

CN est. 2018

Single-port endoscopic surgical robotics built on dual continuum mechanisms

Raised
$100M
Stage
S-D
65

Valar Labs

est. 2021
Raised
$26M
Stage
S-A
65